FDA Approvals Roundup: Korsuva, Jardiance, Xarelto

A weekly update on new drug approvals and indications from the US Food and Drug Administration (FDA).

New approvals
Korsuva okayed for treating moderate-to-severe pruritus in hemodialysis patients
Cara Therapeutics’ Korsuva (difelikefalin injection) has been approved for treating moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis.